Table 2.
Mean ± SD | R | P | |
---|---|---|---|
FMD% | 4.6 ± 2.5 | ||
BD (mm) | 3.6 ± 0.7 | ||
PD (mm) | 3.8 ± 0.7 | ||
Platelet Variable % | |||
MPA NA | 4.1 ± 1.4 | 0.193 | 0.175 |
MPA ADP1.5 μmol/L | 47.8 ± 16.8 | −0.128 | 0.369 |
MPA AA10 μg/mL | 20.8 ± 25.3 | −0.122 | 0.396 |
MPA Coll 1.5 μg/mL | 5.3 ± 5.5 | 0.136 | 0.34 |
PAC‐1 NA (n = 50) | 4.7 ± 5.4 | −0.113 | 0.433 |
PAC‐1 AA10 μg/mL (n = 50) | 23.3 ± 17.3 | −0.045 | 0.755 |
PAC‐1 Coll 1.5 μg/mL | 22.3 ± 20.6 | 0.174 | 0.223 |
CD62P NA (n = 50) | 1.8 ± 1.4 | −0.078 | 0.591 |
CD62P ADP1.5 μmol/L | 58.7 ± 19.1 | −0.237 | 0.094 |
CD62P AA10 μg/mL (n = 50) | 13.5 ± 11.8 | −0.142 | 0.324 |
CD62P Coll 1.5 μg/mL | 8.8 ± 10.1 | −0.077 | 0.591 |
FMD, Flow‐mediated dilation, BD, baseline diameter, PD, peak diameter, Monocyte‐platelet aggregate MPA, No agonist NA, Adenosine diphosphate ADP, Arachidonic acid AA, Collagen Coll. N = 51 unless stated otherwise.